..all doses of ADX10059 abolished levodopa induced dyskinesia...
Sounds cautiously promising.
------------------------------------------------------------------------------------ Addex Pharmaceuticals said its lead product, ADX10059, which is nearing completion of Phase IIb testing in gastroesophageal reflux disease and migraine prevention, also has demonstrated significant potential in a non-human primate model of Parkinson's disease levodopa induced dyskinesia. In a recently completed study, all doses of ADX10059 abolished levodopa induced dyskinesia in the first hour after levodopa administration. There was no adverse effect on Parkinsonian disability scoring. PD-LID currently has no approved therapy and there are an estimated 1.2 million patients with PD-LID in the U.S. http://www.marketwatch.com/story/add...ial-2009-09-14 |
That's very encouraging. End of dose dyskinesia is a real work out.
thanks for posting, paula |
the question is, Paula
The question is, Paula, "will this help or hinder the unusual beauty of your midnight dancing?" (Or mine down the road a pace?) Hugs, Rose :)
|
aahh rose of his heart
my midnight dancing is rhythm induced by music with a beat. ..much groovier. lol
disco-nesia was never my thing, although i love some of the music. Bee Gees, to mention only one of many, and I will never stop laughing out loud when I recall the perm I talked my husband into getting.....hahaha laughing out loud right now! :D paula |
All times are GMT -5. The time now is 08:32 PM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.